Madison El-Saadi

Stock Analyst at B. Riley Securities

(4.59)
# 458
Out of 5,182 analysts
16
Total ratings
73.33%
Success rate
24.51%
Average return

Stocks Rated by Madison El-Saadi

COMPASS Pathways
Apr 24, 2026
Initiates: Buy
Price Target: $17
Current: $8.89
Upside: +91.23%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26$31
Current: $23.45
Upside: +32.20%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50$63
Current: $35.10
Upside: +79.49%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61$101
Current: $73.60
Upside: +37.23%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11$14
Current: $6.79
Upside: +106.19%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19$37
Current: $6.94
Upside: +433.14%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $187.40
Upside: -4.48%